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Highlights 
 
1. HRV is associated with executive function, but causal pathways remain to be examined 
2. Available evidence provides a framework on which potential mechanisms are explored 
3. Insulin resistance and atherosclerosis mediated the HRV-cognition relationship in seriatim  






BACKGROUND: Research has linked high-frequency heart rate variability (HF-HRV) to cognitive 
function. The present study adopts a modern path modelling approach to understand potential 
causal pathways that may underpin this relationship. 
 
METHODS: Here we examine the association between resting-state HF-HRV and executive 
function in a large sample of civil servants from Brazil (N=8,114) recruited for the Brazilian 
Longitudinal Study of Adult Health (ELSA-Brasil). HF-HRV was calculated from 10-minute 
resting-state electrocardiograms. Executive function was assessed using the trail-making test 
(version B).  
 
RESULTS AND CONCLUSIONS: Insulin resistance (a marker of type 2 diabetes mellitus) and 
carotid intima-media thickness (subclinical atherosclerosis) mediated the relationship between HRV 
and executive function in seriatim. A limitation of the present study is its cross-sectional design; 
therefore, conclusions must be confirmed in longitudinal study. Nevertheless, findings support that 
possibility that HRV provides a ‘spark’ that initiates a cascade of adverse downstream effects that 
subsequently leads to cognitive impairment. 
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An increasing body of research highlights important links between cardiac function and cognition, 
resonating with Aristotelian thinking (Gross, 1995) on the functional role of the heart. Vagal nerve 
stimulation in humans has been shown to influence higher-order cognitive processing including 
executive function (Sackeim et al., 2001; Vonck et al., 2014). Other studies have demonstrated that 
reduced high-frequency HRV (HF-HRV) – an index of cardiac vagal function (Cacioppo, 
Tassinary, & Berntson, 2007) – is associated with a 6.7-fold increase in odds for cognitive 
impairment in older women (Kim et al., 2006), and that experimental modulation of HRV improves 
prefrontal cognitive function in both young (Hansen, Thayer, Johnsen, Sollers, & Stenvik, 2004) 
and older (Albinet, Boucard, Bouquet, & Audiffren, 2010) participants. Furthermore, recent 
epidemiological studies have shown that poor cardiovascular health is associated with future 
cognitive impairment (Reis et al., 2013; Thacker et al., 2014). Therefore, efforts to improve 
cardiovascular health – consistent with the American Heart Association strategic goals for 2020 and 
beyond (Lloyd-Jones et al., 2010) – may have important implications for cognitive outcomes later 
in life, including delaying onset of dementia. Here we examine the association between resting-state 
HF-HRV – an important marker of cardiac health – and executive function in civil servants 
recruited in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) (Aquino et al., 2012; 
Schmidt et al., 2014) using a modern path modelling approach (Hayes, 2013). 
 
Despite an increasing body of evidence linking HRV to cognitive function, the underlying pathways 
mediating this relationship remain unclear. Despite this, the available evidence provides a solid 
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framework on which potential mechanisms may be explored. Vagal nerve function – commonly 
indexed by HF-HRV – plays an important role in regulating the inflammatory reflex (Tracey, 
2002a; Tracey & Pavlov, 2012), a neural mechanism involved in metabolic homeostasis and rapid 
control of innate immune responses, just as it controls heart rate and other vital functions. In this 
regard, reduced resting-state HRV may reflect a poorly functioning anti-inflammatory reflex 
(Jarczok, Koenig, Mauss, Fischer, & Thayer, 2014; Kemp & Quintana, 2013; Tracey & Pavlov, 
2012), leading to chronic inflammation and the development of insulin resistance (Donath & 
Shoelson, 2011; Hotamisligil, 2006), a syndrome that subsequently contributes to progressive 
atherosclerosis (DeFronzo, 2010) and cognitive impairment (Zhong et al., 2012). Decreased vagal 
nerve function leads to impaired hepatic vagal nerve signalling and baroreflex sensitivity that is 
causally associated with insulin resistance (Miller, Sims, Canavan, Hsu, & Ujhelyi, 1999; Ribeiro, 
Lautt, Legare, & Macedo, 2005; Tracey & Pavlov, 2012). Insulin resistance is a hallmark of type 2 
diabetes mellitus and is strongly associated with a cluster of metabolic and cardiovascular risk 
factors including dyslipidaemia, hypertension, obesity, glucose intolerance and endothelial 
dysfunction (DeFronzo, 2010; Kashyap & Defronzo, 2007), and these components may actually 
contribute to predementia syndromes and the evolution of dementia (Panza et al., 2012).  
 
Chronic inflammation also plays an important role in the pathophysiology of metabolic risk factors 
(i.e. the metabolic syndrome) (Haffner, 2006). Longitudinal studies have demonstrated that the 
metabolic syndrome leads to cognitive decline over a 3-year period in an elderly Latino population, 
and these findings were especially pronounced in individuals with high serum levels of 
inflammation (median high-sensitivity C-reactive protein level ≥ 3.2mg/L) (Yaffe et al., 2007). 
Insulin resistance also has proatherogenic effects at the level of the arterial wall, that subsequently 
lead to cellular events critical for plaque progression (Reddy, Singh, Bangit, & Batsell, 2010; 
Tabas, Tall, & Accili, 2010) (see also: Karrowni et al., 2013). Inflammation also contributes to the 
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development of atherosclerosis (Ross, 1993; 1999), further suggesting an important role for reduced 
vagal function in the accumulation of lipids and hardening of the arterial wall.  
 
Carotid intima-media thickness (IMT) is a non-invasive surrogate measurement for subclinical 
atherosclerosis (Touboul et al., 2012), associated with cognitive impairment and cognitive test 
performance ten years later (Zhong et al., 2012). In that study (Zhong et al., 2012), larger IMT was 
associated with longer time to complete the Trail-Making Test (part B) – a commonly employed 
measure of executive function employed in the present study – after multiple adjustments. The 
authors (Zhong et al., 2012) proposed three possible mechanisms for the association between 
carotid atherosclerosis and cognitive function including: 1) unstable plaque peeling off, causing 
cerebral emboli, stroke and vascular dementia, 2) silent stroke damaging the brain and causing 
cognitive impairment, and 3) chronic cerebral hypo-perfusion and ischemia, increasing the 
vulnerability of neurons and subsequently impacting on cognitive performance. Interestingly, it has 
recently been shown that low resting HRV is associated with decreased resting brain perfusion as 
measured by pulsed arterial spin labelling (Allen, Jennings, Gianaros, Thayer, & Manuck, 2015). 
We suggest here that the adverse, downstream effects of reduced HRV may include insulin 
resistance subsequently leading to increased atherosclerosis, which will contribute to cognitive 
impairment. This is the model we sought to test in the present study. 
 
We hypothesised that insulin resistance and atherosclerosis would mediate the relationship between 
HRV and executive function in a relatively large cohort of individuals from Brazil. We further 
sought to determine whether a single serial pathway of multiple mediators, or multiple indirect 
pathways underpinned this relationship. For instance, it is possible that reduced HRV directly 
contributes to atherosclerosis, beyond any contribution from insulin resistance. It is also possible 
that insulin resistance itself contributes directly to impairment in cognitive function (McCrimmon, 
Ryan, & Frier, 2012; Talbot et al., 2012). While we expected an important role of insulin resistance 
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and atherosclerosis as mediating factors between HRV and executive function, we sought to 
determine, which particular pathways best explain this association. To our knowledge this is the 





ELSA-Brasil is a cohort of 15,105 civil servants aged 35 to 74 enrolled between August 2008 and 
December 2010 at six cities (Belo Horizonte, Porto Alegre, Río de Janeiro, Salvador, São Paulo and 
Vitória). Exclusion criteria for the ELSA-Brasil study included current or recent pregnancy (within 
4 months of first interview), intention to quit working at the institution in the near future, severe 
cognitive or communication impairment, and if retired, residence outside of a study centre’s 
metropolitan area. ELSA-Brasil is an ongoing cohort study designed to investigate the development 
and progression of chronic diseases including cardiovascular diseases, diabetes and dementia 
(Aquino et al., 2012; Passos, Caramelli, Benseñor, Giatti, & Barreto, 2014; Schmidt et al., 2014). 
The ethics committees of the participating universities approved the research protocol. All 
participants provided written informed consent after a complete description of the study. 
 
Data from participants completing the Trail Making Test (TMT, version B) – a measure of 
executive function – was available for 13,142 participants after excluding participants (n= 1,963) 
with a history of stroke or those using medications known to interfere with cognition (neuroleptics, 
anticonvulsants, anticholinesterase or antiparkinsonian agents), as well as those participants who 
were not able to complete the test within 5-minutes. Analyses were conducted on cases with 
complete data (N=8,114). (See section on Participant Characteristics for further information). 
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Procedure 
Participants were asked to abstain from caffeine, alcohol and physical activity 12 hours prior to 
assessments, described below. (See also Aquino et al., 2012; Schmidt et al., 2014).  
 
Measures 
Heart rate variability (HRV): Ten-minute, resting-state electrocardiogram (ECG) was recorded 
from participants in the supine position during spontaneous breathing without task demands. The 
ECG was always collected in the morning (8:00 to 12:00h) in a temperature-controlled room (21-
24°C). Lead II ECG signals were recorded at 250 Hz with a digital electrocardiograph (Micromed, 
Brazil), consistent with international standards for the collection of heart rate variability (Task 
Force of the European Society of Cardiology and the North American Society of Pacing and 
Electrophysiology, 1996). (see also R. J. Ellis, Zhu, Koenig, Thayer, & Wang, 2015). Wincardio 
(4.4a) software generated the R-R interval series from a lead associated with the highest ECG R-
wave amplitude (usually D2). We have described the artefact detection and spectral analytic 
techniques previously (Dantas et al., 2012; Kemp et al., 2014a). Briefly, the R-R series was 
automatically preprocessed to remove ectopic beats and artifact, and linear interpolation was 
employed to replace any removed beats. Power spectral analysis was carried out by autoregressive 
modeling, estimated by the Yule Walker method, using the recursive algorithm of Levinson-Durbin. 
The high frequency (HF; 0.15–0.40 Hz) component was estimated, expressed in absolute units and 
then log-transformed as a normalisation strategy. The root mean square of successive differences 
(RMSSD), a commonly reported time-domain measure of heart rate variability was also extracted 
from participant data for sensitivity analysis. While RMSSD is highly correlated with HF-HRV 
(Goedhart, Van Der Sluis, & Houtveen, 2007), the former may be less affected by changes in 
breathing frequency (Penttilä et al., 2001; Saboul, Pialoux, & Hautier, 2013). While HRV is 
generally accepted to index cardiac vagal function (Cacioppo et al., 2007), there are several caveats 
to its interpretation (e.g. Berntson et al., 1997; Grossman & Kollai, 1993). 
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Trail Making Test (TMT; major outcome measure of cognitive performance): We focus on the TMT 
(version B) given work highlighting a relationship between HRV and executive function (Thayer, 
Hansen, Saus-Rose, & Johnsen, 2009), as well as a more recent study (Zhong et al., 2012) that 
reported higher IMT at baseline to be associated with longer time to complete this task at a 10-year 
follow-up assessment. The TMT (version B) is a widely used test of executive functions including 
cognitive flexibility, attention, concentration and psychomotor speed (Bowie & Harvey, 2006). 
Methodological detail relating to all cognitive testing in the ELSA study has been previously 
described (Passos et al., 2014). The TMT task requires participants to draw lines connecting letters 
and numbers in an order that alternated between increasing numeric value and alphabetic order (1, 
A, 2, B, 3, C etc). Participants must complete the task as quickly as they can without lifting the 
pencil point from the page. The total time (in seconds) to complete the Trails Test B is then 
recorded.  
 
Homeostasis Model Assessment Index for Insulin Resistance (HOMA-IR, first mediator): Blood 
samples were collected after a 12-hour fast. Serum glucose levels were determined using the 
Hexokinase method (ADVIA Chemistry; Siemens, Deerfield, Illinois). Fasting insulin levels were 
measured using the immunoenzymatic assay (ELISA) (Siemens). The homeostasis model 
assessment (HOMA) index for insulin resistance was then calculated using the following formula: 
(Glucose (mg/dl) * Insulin (mcUI/mL))/405.  This method (originally described by D. R. Matthews 
et al., 1985) is highly correlated with insulin resistance as measured by the euglycemic-
hyperinsulinemic clamp method. It is also a relatively simple, non-invasive alternative that makes it 
particularly suitable for epidemiological studies (Hrebícek, Janout, Malincíková, Horáková, & 
Cízek, 2002) such as ELSA-Brasil. 
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Carotid intima-media thickness (IMT, second mediator): The technique for IMT measurement in 
the ELSA-Brasil study has been described previously (Mill, Pinto, Griep, & Goulart, 2013; Santos, 
Bittencourt, et al., n.d.; Santos, Goulart, et al., n.d.). The same protocol was performed in all centers 
using a Toshiba (Aplio XG™) with a 7.5 MHz linear transducer. IMT was measured in the outer 
wall of a pre-defined carotid segment of 1 cm in length from 1 cm below carotid bifurcation, during 
three cardiac cycles. All participating centers obtained the carotid images during three cardiac 
cycles and sent these acquisitions to the centralized reading center in São Paulo. The validity of 
acquired images was established by clearly visualising: (1) the anatomic guides for the common 
carotid arteries, (2) interfaces between the lumen and the vessel far wall and, (3) the interfaces 
between the media and the adventitia layers of the far vessel wall. The average of the maximum 
values of right and left common carotid artery IMT was used in analysis.  
 
Covariates 
Covariates included demographic characteristics, age, sex, education (less than high school vs 
other), ethnicity (black vs other), physical activity (sedentary vs other, determined using scoring 
guidelines for the International Physical Activity Questionnaire) (Craig et al., 2003), the severity of 
depression and anxiety (as measured by the total score from the Clinical Interview Schedule-
Revised, CIS-R) (Lewis, Pelosi, Araya, & Dunn, 1992; Nunes, de Mello Alves, Chor, Schmidt, & 
Duncan, 2012), smoking (current vs other), and use of other cardiovascular and psychoactive 
medications not previously excluded (see section on Participants) (yes vs no).1 Less “than high 
school level of education,  ‘black’ ethnicity, low levels of physical activity, smoking and use of 
medications may be associated with altered levels of HRV, heightened cardiovascular risk and 
impaired cognitive performance (especially in older cohorts), and may therefore confound 
unadjusted associations between variables of interest. Depression and anxiety are also associated 
                                                        
1 We would like to note here that we also ran additional analysis, which separated this single 
medication covariate into either cardiovascular and psychoactive medications (ATC 
classification C versus N: http://www.whocc.no/atc_ddd_index/), and findings do not differ 
from those that we report in the body of our manuscript. (See also our third footnote). 
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with our variables of interest (Kemp et al., 2014a; Kemp, Quintana, Felmingham, Matthews, & 
Jelinek, 2012; Kemp, Quintana, Quinn, Hopkinson, & Harris, 2014b), and as preliminary modelling 
indicated that depression did not moderate (or mediate) pathways between HRV and executive 
function, a measure of the severity of depression and anxiety was also added as a covariate.  
 
Statistical Methods 
Descriptive information is presented in Table 1 for all participants with complete data (N=8,114), as 
well as by tertile of high-frequency HRV (HF-HRV) to aid interpretation. Path modelling was then 
conducted to examine the direct effects (i.e. HF-HRV on executive function) and indirect 
(mediating) effects  (i.e. relationships between HRV and executive function via the mediators, 
HOMA-IR and IMT) to test our hypotheses. A series of mediation models are presented, which 
quantify the direct and indirect pathways through which an antecedent (predictor or independent) 
variable transmits its effect on a consequent (dependent or outcome) variable. Mediation modelling 
is a suitable analytic approach for testing predicted directional relationships in cross-sectional 
datasets (Hayes, 2013). Our conceptual model – in which HRV transmits its effects on cognitive 
function through insulin resistance (our first mediator) followed by IMT (second mediator)– is 
presented in Figure 1. Results for an alternative model – in which insulin resistance and IMT 
transmit their effects on HRV, which subsequently impacts on cognitive function – is presented in 
the supplementary information.  
 
Modelling involved ordinary least squares path analysis using the add-on PROCESS tool (Hayes, 
2013) in SPSS (version 21) (Hayes, 2013). The path modelling approach (Hayes, 2013) that we 
employ here has three major advantages over the traditional approach to testing mediation (Baron & 
Kenny, 1986). These are: 1) the capacity to determine whether there is a significant indirect effect, 
quantify this effect and determine whether distinct indirect pathways significantly differ from each 
other, 2) the application of a nonparametric bootstrapping mediation method, which doesn’t make 
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assumptions regarding the distribution of the regression coefficients of the direct effect, and 3) the 
application of a more powerful approach to conducting inferential statistics (see Hayes, 2013). 
 
Results from path modelling were derived from 10,000 bootstrapped samples; unstandardized 
parameter estimates (B), heteroscedastic-consistent standard errors and bias-corrected 95% 
confidence intervals (95% CI) determined the significance of direct and indirect associations 
(Hayes, 2013). Consistent with recommendations for the reporting of findings from observational 
studies in epidemiology (Vandenbroucke et al., 2007), unadjusted and adjusted findings are 
reported. Two effect size measures for the total indirect effect are reported (as described in Hayes, 
2013). These include the ratio of the indirect effect to the total (and direct) effect reflecting the 
proportion of the total (and direct) effect occurring indirectly. Additional analyses on two randomly 
selected subsamples (~50%) were then conducted to determine the robustness of findings in the 
entire cohort (i.e. could findings be replicated in two randomly selected subsamples from the entire 
sample?) in order to establish the extent to which findings are replicable. These results are reported 
in the supplementary information.  
 
It should be noted here that it is not the point of modern path modelling to determine the best fitting 
model given the data, in the same way that structural equation modelling is sometimes practiced 
(Hayes, 2013). Instead, the goal is to estimate and interpret the effects that are predicted on the 




The potential impact of missing data was first examined by comparing the characteristics of 
participants with and without missing data. Analyses was carried out on a total of 8,114 participants 
after excluding participants that did not have data available for any of the additional variables 
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entered into analyses, including covariates (n= 5,028). Carotid IMT assessments and HRV data 
were available for 10,943 and 13,796 participants, respectively, due to local data collection issues. 
An additional 504 participants were excluded from HRV analyses due to the presence of ectopic 
beats. Other measures on which data was missing included the Homeostasis Model Assessment 
Index for Insulin Resistance (HOMA-IR) (n=19), race (n=184), activity level (n=223), and severity 
of depression (n=11). Relative to cases completing the Trail Making Test (N=13,142 after 
exclusions; see description of participants in Methods section), cases included in analyses 
(N=8,114) were slightly younger (51.17 years versus 51.66 years; p=0.002, Cohen’s d = 0.05), were 
more likely to be female (St. Residual = 1.6, 𝜒2=14.43, p<0.001, r=0.03), white (St. Residual = 3.8, 
𝜒2=86.94, p<0.001, r=0.08), have had less than a high school level of education (St. Residual = 1.7, 
𝜒2=8.52, p=0.004, r=0.03). Included cases were also less likely to have diabetes mellitus (St. 
Residual = -1.7, 𝜒2=9.68, p= 0.002, r=0.03), and to be using medications (St. Residual = -2.2, 
𝜒2=20.35, p<0.001, r= 0.04). However, these differences are very small according to effect size 
measures (Cohen’s d and r), and are unlikely to have biased results to any meaningful extent.  
 
Table 1 provides information relating to the characteristics of the participants with complete data 
(N=8,114). This table also presents group characteristics by HF-HRV tertiles to aid interpretation of 
characteristics according to HF-HRV, our focal predictor [high tertile, M = 6.60, SD = 0.54; middle 
tertile, M = 5.43, SD = 0.28; low tertile, M = 4.10, SD = 0.71]. Relative to those in the highest HF-
HRV tertile, those in the lowest tertile were associated with older age, fewer women, more 
participants with reported ‘white’ ethnicity and few participants with ‘brown’ or ‘black’ ethnicity, 
less education, fewer participants engaged in high levels of physical activity, fewer current 
smokers, higher level of insulin resistance, more participants with diabetes, greater carotid IMT, 
more cases with ‘hard’ coronary heart disease (CHD) (i.e. history of myocardial infarction or 
coronary revascularisation) and higher heart rate. Participants in the lowest HF-HRV tertile also 
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displayed a slower time to complete the trail-making test, a finding associated with small effect size 
(Cohen’s d = 0.13).  
 
Multiple Mediation Modelling 
Results from our unadjusted serial mediation model revealed significant direct (B = -0.0165, 95% 
CI: -0.0246, -0.0085) and (total) indirect effects (B = -0.0095, 95% CI: -0.0117, -0.0074) for HRV 
on time taken to complete the trails test (Table 2, Fig 2). Two significant indirect pathways were 
identified: the first included paths a1  d21  b2 (see Fig 1) (B = -0.0027, 95% CI: -0.0032, -
0.0022), while the second included paths a2  b2 (B = -0.0070, 95% CI: -0.0088, -0.0054) (Fig 2). 
The ratio of the indirect effect to the total effect, a measure of effect size, is 0.3644, indicating that 
36% of the effect of HRV on executive function occurs indirectly. (The indirect effect is 57% of the 
size of the direct effect.)  
 
Results from adjusted analyses (Table 3; Fig 3) provides evidence for a serial pathway of multiple 
mediators including HOMA-IR (insulin resistance) followed by IMT (carotid intima-media 
thickness) after controlling for a host of potential confounding factors in all of the regressions that 
comprised the mediation analysis. This finding indicates that the association between HRV and 
time to complete the trails test is mediated by HOMA-IR and IMT (a1  d21  b2; full sample 
effect = -0.0003, 95% CI: -0.0005, -0.0002) (Table 3, Fig 3).2,3 Additional analyses (reported in 
supplementary information; supplementary tables 1 and 2, and supplementary figures 1 and 2) 
                                                        
2 In these analyses, we did not control for certain variables, such as dyslipidemia and 
hypertension, considered to lie on the theoretical pathway between HRV and executive 
function. These factors are generally considered to be central features of the ‘insulin 
resistance syndrome’ (DeFronzo, 2010; Kashyap & Defronzo, 2007), the basic cause of which 
is insulin resistance, a variable included in the analysis as the first major mediator. However, 
further analyses were run which included these variables, and our main finding of a single 
mediating pathway via HOMA-IR and IMT was found to be robust to the inclusion of these 
additional covariates into the model (full sample effect = -0.0002, 95% CI: -0.0004, -0.0001). 
3 We also ran a further analysis, which included a cardiovascular medication covariate (ATC 
classification C) and a psychoactive medication covariate (ATC classification N), and findings 
indicating a single mediating pathway via HOMA-IR and IMT do not change (full sample effect 
= -0.0003, 95% CI: -0.0005, -0.0002). 
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revealed that the mediating pathway via HOMA-IR and IMT is replicable in two randomly selected 
subsamples highlighting the robustness of the findings observed in the entire cohort (Table 3, Fig 
3). While the second mediating pathway via IMT (a2  b2) was also significant for the full sample 
(B = 0.0005, 95% CI: 0.0001, 0.0010) (Fig 2, Fig 3), it could not be replicated in additional 
analyses on the two randomly selected subsamples. Notably, while the single serial-mediating 
pathway was robust to control for potential confounding factors, the total and direct effects between 
HRV and trail-making test were no longer significant. It is worth noting here the impact that 
adjusting for covariates have on path b2 in particular (compare Fig 2, which reports unadjusted 
findings versus Fig 3, which reports adjusted findings). Following adjustment, paths a1 (which 
refers to the negative relationship between HRV and insulin resistance) and b2 (which refers to the 
positive relationship between IMT and slowing on the Trail Making Task) sum to near zero. This 
alteration in path coefficients is likely to have contributed to the loss of the significant total effect 
observed in Figure 2, and in part, helps to better understand the small effect associated with the 
overall singular mediating pathway.  
 
Our alternative model determined whether insulin resistance and IMT transmit their effects on 
HRV, which subsequently impacts on performance in the TMT taking into account all covariates. 
Results provide evidence against this alternative explanation for the relationship between HRV and 
TMT in our cohort (supplementary Fig 3). No paths involving HRV as the second mediator were 
significant. Therefore, this model fails to link HRV to performance on the trail-making task after 
controlling for covariates, unlike the results reported in Table 3 and Fig 3. Finally, additional 
sensitivity analyses were conducted. The first on RMSSD as the measure of HRV replicated the 
findings reported above on HF-HRV (see supplementary information: Table 4 and Figure 4). The 
second on heart rate instead of HRV (see supplementary figure 5) failed to replicate the findings 
observed for HRV. 
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Discussion 
The present study sought to better understand the relationship between HRV and performance on an 
executive function task through modelling of specific variables that may lie on the causal pathway. 
Key findings from the present study were that 1) participants with high HRV performed better on 
the trail-making test – a measure of executive function – than those with low HRV, a finding 
associated with a small effect size (Cohen’s d = 0.13) and approximately a third of this effect was 
observed to occur indirectly, 2) there is a single, serial multiple-mediator pathway linking HRV and 
executive function by insulin resistance and subclinical atherosclerosis and these findings were 
robust to the adjustment of potential confounding variables, and 3) the validity of this single, serial 
multiple-mediator pathway was supported in four different sensitivity analyses (reported in the 
supplementary information). These additional analyses include the 1) replication of findings in two 
randomly selected subsamples from the entire cohort reinforcing the confidence in our findings 
(reported in supplementary tables and figures 1 and 2), 2) failure to support an alternative model in 
which insulin resistance and IMT drive alterations in HRV, which subsequently affects performance 
on the trail-making test (supplementary table and figure 3), 3) replication of findings using 
RMSSD, an alternative, commonly-reported measure of HRV that may be less affected by 
alterations in respiration (supplementary table and figure 4), and 4) the failure to replicate findings 
when HRV was replaced by heart rate (supplementary Figure 5). Finally, it is also worth noting 
here that although effects are small, the finding is replicable in two randomly selected subsamples 
(as reported above, and presented in supplementary information). In summary, our study makes a 
novel contribution to the literature on the relation between cardiac and cognitive function, 
identifying a single mediating pathway of multiple mediators that contribute seriatim to variance in 
cognitive function. 
 
We suggest that our findings are practically significant for at least four reasons. (See P. D. Ellis, 
2010 for a detailed discussion of the concept of practical significance). First, research findings are 
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consistent with our proposed hypotheses based on the available literature (i.e. the “theoretical 
plausibility” rationale). There is now a large body of theoretical and experimental evidence that 
causally links dysregulation in the anti-inflammatory reflex – indexed by reductions in HRV – to 
insulin resistance (Donath & Shoelson, 2011; Hotamisligil, 2006; Tracey & Pavlov, 2012), a 
syndrome associated with progressive atherosclerosis (Beckman, Creager, & Libby, 2002; 
DeFronzo, 2010), which is itself associated with cognitive impairment, including longer time to 
complete the Trail-Making Test (Zhong et al., 2012). Second, while the relationships we observed 
here are small in size, small effects may trigger adverse downstream effects that accumulate over 
time to become large effects (i.e. the "small sparks start big fires" rationale). Vagal nerve 
dysfunction is known to lead to chronic inflammation (Jarczok et al., 2014; Tracey, 2002b; Tracey 
& Pavlov, 2012), which may subsequently lead to a variety of conditions including psychiatric 
disorders (Dantzer, O'Connor, Freund, Johnson, & Kelley, 2008) and cardiovascular disease 
(Hansson, 2005), conditions known to be associated with cognitive impairment (Caspi et al., 2014; 
Morris & Cuthbert, 2012; Snyder, 2013; Thacker et al., 2014). We suggest that HRV may be 
considered the ‘spark’ that initiates a cascade of adverse downstream effects subsequently leading 
to cognitive impairment. Third, we provide new evidence for a regulatory role of vagal function 
over a variety of downstream processes that subsequently impact on cognition (i.e. the “contribution 
to the literature” rationale). These findings were further strengthened by replication in two 
randomly selected subsamples, as well as evidence against the alternative explanation that insulin 
resistance (HOMA) and IMT transmit their effects on HRV, which subsequently impact on 
cognitive function. Although we acknowledge the limitations associated with testing reverse 
causality (Wiedermann & Eye, 2015), our proposed model is in line with a significant body of 
research indicating that low HRV precedes other risk factors (Jarczok et al., 2014; Thayer & 
Sternberg, 2006; Thayer, Yamamoto, & Brosschot, 2010; Tracey & Pavlov, 2012). Fourth, we 
provide evidence for a single pathway that mediates executive dysfunction; no additional pathways 
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were observed to mediate the effect of HRV on executive function (i.e. the “elimination of 
competing explanations” rationale).  
 
Our study has a number of strengths including the application of a modern path modelling approach 
to understand the relationship between HRV and executive function in a relatively large cohort, the 
confirmation of initial findings on two randomly selected subsamples, demonstrating the validity of 
the findings reported here, and a comparison of alternative paths within the same model as well as 
comparison against an alternative model, reinforcing confidence in our findings. We also 
demonstrated that the findings were replicable when replacing HF-HRV with RMSSD, a time-
domain measure of HRV that may be less susceptible to the effects of respiration (Penttilä et al., 
2001; Saboul et al., 2013).  
 
It is also important to acknowledge a number of limitations associated with our study. First, the 
reliability of short-term measurements of HRV has been questioned (Sandercock, Bromley, & 
Brodie, 2005) highlighting the importance of the conditions during which data are collected. 
However, reliable and valid measures of HRV can be obtained from shorter recordings under 
standardized and controlled conditions (Anonymous, 1996). We have also demonstrated that the 
protocol on which this study is based shows good reproducibility (Dantas et al., 2010). Second, we 
did not collect data on respiration rate or tidal volume, which may influence estimates of HRV. 
While researchers have suggested several approaches to controlling for these factors (e.g. Berntson 
et al., 1997; Grossman & Taylor, 2007), the question over whether they should be controlled 
remains a divisive one in the field of psychophysiology (Denver, Reed, & Porges, 2007; Porges, 
2007; Ritz, 2009; Thayer, Loerbroks, & Sternberg, 2011). Third, a weakness of our study is the 
cross-sectional design. Therefore, we only present evidence of covariation between the variables in 
our model consistent with available evidence for a mediating relationship by insulin resistance and 
atherosclerosis. While mediation modelling on cross-sectional datasets is an accepted analytic 
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approach for testing predicted directional relationships (Hayes, 2013), longitudinal studies are of 
course needed to confirm the findings we report here. Finally, findings were based on complete case 
analysis after dropping participants according to listwise deletion procedures given limitations of 
the software used. The task of integrating missing data imputation procedures with mediation 
analysis is complicated by the need to combine results according to Rubin’s rules to account for 
missing-data uncertainty (Rubin, 2009; Schafer, 1997), and the development of such tools (i.e. 
those that allow for data imputation followed by mediation modelling) is still in their infancy. 
While complete case analysis is standard practice in the estimation of mediation models, they may 
be characterised by biased parameter estimates and loss of power. However, only small differences 
were observed on participant characteristics between those cases included and excluded in analyses, 
and findings were consistent with hypotheses and the available literature minimising the importance 
of any bias that may have impacted on parameter estimates. Loss of statistical power is also 
unlikely to be a major issue given the large sample on which findings are based.  
 
In summary, the present study provides new evidence for a single, serial mediating pathway that 
may link HRV reductions to cognitive impairment, reinforcing a potential regulatory role of vagal 
function – indexed by HRV – over a variety of downstream processes that subsequently impact on 
cognition. While we do not claim that the pathway we observe here is the only pathway that might 
mediate the relationship between HRV and executive function, we do suggest that our findings are 
likely to be one of the pathways underpinning the relationship between HRV and executive 
function, and that the alternative pathways we examined may be less important. Future analysis 
exploring more complex models – including for example, whether mediators of the relationship 
between HRV and cognitive function are moderated – would be welcomed. Simple health 
behaviours including weight loss, smoking cessation, physical exercise, mediation and use of 
positive emotions are all associated with increased HRV, and may therefore provide opportunities 
to short circuit the deleterious effects of associated with chronic vagal impairment. 
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Figure Captions 
 
Fig 1: The conceptual serial mediation model for the relationship between HRV and executive 





Fig 2: Path coefficients for unadjusted mediation model for entire sample with complete data 
(N=8,114). Results provide evidence for indirect paths between HRV and the trail-making test 
HOMA-IR and IMT (a1→d21→b2; bolded path 1) and via IMT (a2→ b2; bolded path 2). See also 




Fig 3: Path coefficients for adjusted mediation model for entire sample with complete data 
(N=8,114) after adjusting for covariates including age, gender, level of education, ethnicity, 
physical activity, depression severity, smoking status and medication use. Results provide evidence 
for an indirect path between HRV and the trail-making test via HOMA-IR and IMT (a1→d21→b2; 
bolded path). This path significantly differs from alternate path via a2 (dotted line) and b2. See also 
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Table 1: Participant characteristics of those participants that underwent ECG and IMT assessments in the ELSA-Brasil cohort are reported. 
Characteristics are reported by overall sample with complete data (N=8,114) and tertiles on heart rate variability (HF-HRV)*. The effect size 
(Pearson’s r or point biserial correlation) is reported for the correlation between each characteristic and HF-HRV to provide information about the size 
of the relationships. 
Characteristics  Heart rate variability Effect size p-value 
Group 










Age, mean (SD), y 51.17 (8.81) 48.53 (8.22) 50.83 (8.43) * 54.15 (8.87)* -0.28 <0.001 
Women, no., % 4,571 (56.3) 1,663 (61.5) 1,546 (57.2) * 1,358 (50.3) * +0.10 <0.001 
Ethnicity, no., % 
  Whites  
  Browns  










1,582 (58.5) * 
651 (24.1) * 
374 (13.8) * 
 
1,711 (63.3)* 
615 (22.8) * 









Education, no., % 
  <High school  
  High School  











950 (35.1) * 
1,546 (57.2) 
 
272 (10.1) * 










Physical activity, no., % 
  Low level 
  Moderate level 

























Depression Severity, mean (SD) 8.03 (7.80) 8.58 (8.11) 7.85 (7.72)* 7.65 (7.53)* +0.05 <0.001 
Current smoker, yes, % 1,034 (12.7) 398 (14.7) 316 (11.7) 319 (11.8)*  +0.03 0.001 
HOMA-IR1, mean (SD) 2.34 (2.72) 1.98 (1.98) 2.23 (2.40)* 2.81 (3.50)* -0.15 <0.001 
Diabetes, yes, % 1,373 (16.9) 323 (11.9) 385 (14.2) * 665 (24.6) * -0.17 <0.001 
IMT2, mean (SD), mm 0.75 (0.16) 0.72 (0.15) 0.74 (0.16)* 0.77 (0.17)* -0.14 <0.001 
Hard CHD events, yes % 165 (2.0) 36 (1.3) 43 (1.6) 86 (3.2) * -0.05 <0.001 
Medication Use3, yes, % 2,874 (35.4) 794 (29.4) 882 (32.6) * 1,198 (44.3) * -0.14 <0.001 
HR Average3, mean (SD), BPM  66.80 (8.98) 62.78 (7.54) 66.21 (7.93)* 71.40 (9.21)* -0.47 <0.001 
TMT4, mean (SD), seconds 108.64 (50.98) 105.57 (50.38) 107.98 (50.36) 112.41 (52.20)* -0.07 <0.001 
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1HOMA-IR: homeostasis model assessment – insulin resistance; 2IMT: carotid intima-media thickness, average of bilateral maximum; 3Medication 
Use: any medication including lipid reductor, antihypertensives, diuretics, angiotensin II receptor blocker; 4Sample size total corresponds to the 8,114 
participants with complete data; 5Tertile cut-offs for (ln)HF-HRV: low <4.92, middle >4.92 and <5.91, and high > 5.92; * p<0.05 relative to high HRV 
tertile 
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Table 2: Results for the unadjusted serial mediation model on the association between HRV and executive function (trail making test, TMT) for the 
entire sample with complete data (N=8,114). Regression coefficients (unstandardized), standard errors, and model summary information for each 
consequent are provided. See also Fig 2.  
   Consequent 
  M1(HOMA-IR)  M2(IMT)  Y (TMT) 
Antecedent  Coeff. SE p  Coeff. SE p  Coeff. SE p 
X (HRV) a1 -0.1334 0.0091 <0.0001 a2 -0.0178 0.0019 <0.0001 c’ -0.0165 0.0041 0.0001 
M1(HOMA-IR)     d21 0.0507 0.0024 <0.0001 b1 -0.0012 0.0052 0.8232 
M2(IMT)         b2 0.3923 0.0240 <0.0001 
Constant  1.1589 0.0498 <0.0001  -0.2416 0.0110 <0.0001  4.8051 0.0235 <0.0001 
Model Summary  R2=0.0272 
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Table 3: Results for serial mediation model on the association between HRV and executive function (trail making test, TMT), fully adjusted for 
covariates1 for the entire sample with complete data (N=8,114). Regression coefficients (unstandardized), standard errors, and model summary 
information for each consequent are provided. See also Fig 3.  
   Consequent 
  M1(HOMA-IR)  M2(IMT)  Y (TMT) 
Antecedent  Coeff. SE p  Coeff. SE p  Coeff. SE p 
X (HRV) a1 -0.0942 0.0092 <0.001 a2 0.0046 0.0017 0.0083 c’ -0.0040 0.0038 0.2962 
M1(HOMA-IR)     d21 0.0340 0.0022 <0.0001 b1 -0.0041 0.0049 0.4031 
M2(IMT)         b2 0.1052 0.0254 <0.0001 
Constant  0.6852 0.0926 <0.0001  -0.8727 0.0173 <0.0001  3.9947 0.0448 <0.0001 
Model Summary  R2=0.1015 





1 Covariates included age, gender, level of education, ethnicity, physical activity, depression severity, smoking status and medication use 
 
